Intanwijaya Internasional Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Intanwijaya Internasional Tbk trades at Rp650 (market cap 133.94B, 4.2K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 16.01M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 5.1× Intanwijaya Internasional Tbk's market cap, and Charlie Hospital Semarang Tbk. is more actively traded (16.01M versus 4.2K). Which is the better fit depends on your goals.
| INCI | RSCH | |
|---|---|---|
Market Cap | 133.94B | 678.4B |
Volume | 4.2K | 16.01M |
Lot | 42 | 160.07K |
Turnover | 2.73M | 4.11B |
Average Price | 650.12 | 256.89 |
Value | 2.73M | 4.11B |
Indicative Equilibrium Price | — | 258 |
Indicative Equilibrium Volume | — | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Intanwijaya International Tbk (the Company) formerly named as PT Intan Wijaya Chemical Industry Tbk, was established in Jakarta based on the Notarial Deed No. 64 of Jony Frederik Berthold Tumbelaka Sinjal, S.H., dated November 14, 1981.The company's business field in in the Formaldehyde and Formaldehyde Resin Industries with the capacity of 96.000 metrics tons per annum in the form of liquid and 7.000 metric tons per annum in the form of powder and Hexamine 6.000 metric tons per annum.
Read more on INCI →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →